Duality Biologics Suzhou Co Ltd - Health Care Sector

A comprehensive view of Duality Biologics Suzhou Co Ltd. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

BioNTech and DualityBio receive FDA breakthrough therapy designation for antibody-drug conjugate candidate BNT323/DB-1303 in endometrial cancer; over 400,000 cases of endometrial or uterine cancer occurr each year worldwide

Published: December 21, 2023 by GlobeNewswire Europe

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count

CONTACT US

We offer built-to-order industry coverage for our clients. Click on any of the markets or drivers to see a sample intelligence map or call us for a free consultation.

Call Us

310.553.0008

Email Us

info@industryintel.com

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Latest Public Posts

Client-Centric Solutions at Industry Intelligence

September 7, 2023

Information Delivery with a Vision

August 8, 2023

Saving Our Planet with Lignocellulose

April 11, 2022

Useful Links

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

contact@industryintel.com
www.industryintel.com

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.